Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Invitation to Tobii’s webcast following the interim report for the first quarter of 2023

Press release Stockholm, April 27, 2023 Tobii AB (publ) plans to publish the interim report for the period January 1 - March 31, 2023, on May 4 at 7.30 a.m. CET. Following this report, at 9.00 a.m. CET, Tobii will host a presentation for investors, analysts and media. Tobii’s President and CEO Anand Srivatsa and CFO Magdalena Rodell Andersson will present and comment on the report. After the presentation, there will be time for questions. The presentation will be held in English. Details · Time: Thursday May 4, 2023, 9.00 a.m. CET · Webcast: Link to the webcast 

Correction: Quickbit publishes Q3 interim report ‘22/23

Quickbit announces a correction to the press release published yesterday. The correction concerns reference to Significant uncertainty factor regarding Material Uncertainty Related to Going Concern in the auditor's review report. The following two paragraphs are added to the press release and are then followed by the original press release from yesterday.Reference to auditor’s review report The following is stated under the section Material Uncertainty Related to Going Concern: Without qualifying our review report, we draw attention to the Risk and uncertainties section on page 5 in the

UPM Plywood is planning to restructure its organization and scale its operations

(UPM Plywood, Lahti, 27 April 2023 at 13:00 EEST) – UPM Plywood is planning to restructure its organization and scale its operations to meet the reduced production capacity and the deteriorating market situation. The company will begin employee negotiations involving 262 salaried employees in the staff and global functions, in the sales offices and in the Finnish mills. It is estimated that the maximum reduction is 35 positions. Employee negotiations will be conducted in accordance with local legislation. “In the new situation, it is extremely important to renew the company's

Senior Lecturer awarded title of Biomedical Scientist of the Year

A Staffordshire University lecturer has won the title Biomedical Scientist of the Year for his pioneering work which includes the development and delivery of degree apprenticeships.Ian Davies, a Senior Lecturer in the School of Health, Science and Wellbeing, was announced as winner of the prestigious award at the Advancing Healthcare Awards  which celebrates the passion, dedication and innovation of allied health professionals. Ian is course leader for the Healthcare Science degree apprenticeship which

Skanska selected preferred bidder for the construction and O&M for the E10/rv. 85 road project in northern Norway

Skanska has as a part of a consortium been selected by the Norwegian Public Roads Administration (NPRA) as preferred bidder for the E10/rv. 85 Tjeldsund-Gullesfjordbotn-Langvassbukt road project in northern Norway. For Skanska, the scope of the project includes designing, building, and operating and maintaining the road for 15 years from completion.The project, that is being procured as a Public Private Partnership (PPP) by NPRA, is part of the transport link between Lofoten, Vesterålen Harstad/ Narvik Airport and the E6. It includes the construction and operation of 82 kilometers of new

Interim report January – March 2023

· Rental income increased 20 per cent to SEK 1,183 million (983). · Profit from property management increased 1 per cent to SEK 580 million (572). · Changes in the value of properties amounted to SEK -1,255 million (1,734) and changes in the value of financial instruments to SEK 103 million (-3). · Loss after tax for the period amounted to SEK -463 million (1,934). · The market value of the properties amounted to SEK 84,784 million (79,987). · During the period, SEK 649 million (942) was invested in the existing property portfolio. · During the period, 4 properties (17)

Record order intake, solid revenues and profitability

Nacka, Sweden, April 27, 2023: Mats Rahmström, President and CEO of the Atlas Copco Group, comments on the report for Q1 that was released today.“This was a very strong quarter,” said Mats Rahmström. ”Primarily due to several significant orders and strong project-related business, the order intake increased more than expected and reached a new record level.“ Order volumes for industrial compressors increased, driven by larger compressors. For gas and process compressors, the order growth was extraordinary. The demand for power equipment was strong, especially for portable compressors.

Metsä Group’s comparable operating result in January–March 2023 was EUR 276 million

Metsä Group Press release 27 April 2023Metsä Group Interim report January – March 2023 January–March 2023 (1–3/2022) · Sales were EUR 1.634 million (1.594). · Operating result was EUR 276 million (341). Comparable operating result was EUR 276 million (244). · Result before taxes was EUR 271 million (330). Comparable result before taxes was EUR 272 million (232). · Comparable return on capital employed was 15.3% (15.8). · Net cash flow from operations was EUR 38 million (135). Events during the first quarter of 2023 · The average sales prices for Metsä Group’s

Dicot's toxicology program successfully completed

Press release: Uppsala, April 27, 2023. Dicot announces today that the preclinical toxicology program required to start clinical phase 1 trial is completed. LIB-01 has shown a good safety profile in the toxicity studies.Dicot is developing a novel potency drug that aims to become the first choice of  treatment for erectile dysfunction and premature ejaculation. The company plans to start clinical studies with the drug candidate LIB-01 in mid-2023. Today the company announces that the preclinical toxicology program required for clinical phase 1 with LIB-01 has been completed. LIB-01 has

First-quarter report 2023

Record order intake, solid revenues and profitabilityThe comparison figures presented in this report refer to previous year unless otherwise stated.  First quarter · Orders received increased 18% to MSEK 47 707 (40 379), organic growth of 5% · Revenues increased 32% to MSEK 39 861 (30 086), organic growth of 18% · Operating profit reached MSEK 8 699 (6 749), corresponding to a margin of 21.8% (22.4) · Adjusted operating profit, excluding items affecting comparability, was MSEK 8 663 (6 525), corresponding to a margin of 21.7% (21.7) · Profit before tax amounted to

Metsä Board’s comparable operating result in January–March 2023 was EUR 89 million

Metsä Board Corporation Stock exchange release Interim Report 27 April 2023 at 12:00 noon EESTJanuary–March 2023 (compared to 1–3/2022) · Sales were EUR 542.1 million (582.0). · The comparable operating result was EUR 88.7 million 121.5), or 16.4% of sales (20.9). Operating result was EUR 88.4 million (140.7). · Comparable earnings per share were EUR 0.19 (0.26), and earnings per share were EUR 0.19 (0.31). · Comparable return on capital employed was 13.9 % (21.1). · Net cash flow from operations was EUR 126.4 million (92.6).   Events in January–March 2023 · The

Interim Report January-March 2023

AFRY starts the year with strong growth and EBITA development First quarter 2023 – Net sales increased by 22.0 percent to SEK 6,916 million (5,670) – Organic growth adjusted for calendar effects was 15.9 percent (3.3) – EBITA, excl. items affecting comparability, was SEK 689 million (472) – EBITA margin, excl. items affecting comparability, was 10.0 percent (8.3) – EBITA totalled SEK 689 million (359) – EBITA margin was 10.0 percent (6.3) – EBIT (operating profit) amounted to SEK 646 million (317) – Basic earnings per share: SEK 3.85 (1.97) COMMENTS BY THE CEO

Aiforia has received a funding decision from Business Finland to accelerate the development of AI-assisted software solutions for clinical pathology and drug development

Aiforia Technologies Plc, Company release, 27 April 2023 at 12:00 a.m. EEST. Aiforia has received a funding decision from Business Finland to accelerate the development of AI-assisted software solutions for clinical pathology and drug development.The estimated cost for the project is EUR 14,6 million for two years, of which Business Finland will fund a maximum of 50% (EUR 7,3 million) in the form of a loan.  "The growing global market will need the expertise, advanced technologies, and digital solutions of Finnish companies and research organizations. Aiforia is a pioneer in its field

Södra delivers stable result in uncertain times

Södra posted a stable result for the first quarter of 2023. The result reflects the changed market conditions for Södra’s core products, while global turmoil is creating an uncertain outlook.In the first quarter of 2023, net sales for the Södra Group amounted to SEK 8,002 million (8,165), down 2 percent year-on-year. Operating profit totalled SEK 1,085 million (1,974), representing an operating margin of 14 percent (24). Return on capital employed was 19 percent (36) and the equity ratio increased to 68 percent. The first quarter result is an effect of expected and changed market

BioStock: Newly appointed CMO sees potential in Stayble Therapeutics

The Gothenburg-based pharmaceutical company Stayble Therapeutics recently announced Jarkko Kalliomäki as Chief Medical Officer of the company. He is an experienced pain physician and will contribute valuable expertise to the clinical development of the STA363 injection treatment, as well as in future partnership discussions. BioStock interviewed Jarkko Kalliomäki about his new role.Read the full article at biostock.se: https://www.biostock.se/en/2023/04/newly-appointed-cmo-sees-potential-in-stayble-therapeutics/ This is a press release from BioStock - Connecting Innovation & Capital.

BioStock: Article about CombiGene’s epilepsy project published in Gene Therapy

CombiGene recently achieved a milestone with the publication of a scientific article in Gene Therapy, a journal under the Nature Publishing Group. The paper presents the preclinical research findings of CombiGene’s epilepsy project CG01, which has been licensed to Spark Therapeutics.Read the article about CombiGene at biostock.se: https://www.biostock.se/en/2023/04/article-about-combigenes-epilepsy-project-published-in-gene-therapy/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/

Bulletin from Hemnet Group AB (publ)'s annual general meeting 2023

The annual general meeting of Hemnet Group AB (publ), held today Thursday 27 April 2023 in Stockholm, resolved in all parts in accordance with the board of directors' and the nomination committee's proposals to the annual general meeting. Adoption of balance sheets and income statements The annual general meeting approved the balance sheets and income statements of the parent company and the group for the financial year 2022.   DividendThe annual general meeting resolved on a dividend to the shareholders of SEK 1 per share for the financial year 2022. The annual general

Relesys A/S announces results of the Annual General Meeting 2023

Relesys A/S | Resolutions of Annual General Meeting    Company Announcement No. 4-2023 Copenhagen, 27 April, 2023Results of Relesys’ Annual General Meeting 2023     Today, 27th of April, Relesys A/S held its Annual General Meeting 2023 in accordance with the notice and the agenda announced on the 12th of April 2023.     The following resolutions were adopted:  ·Authorization to the chairman of the general meeting, Anne Zeuthen Løkkegaard, with a right of delegation, to make any such amendments and additions to the resolutions passed at the general meeting that may

Paradox Interactive Reveals Final Cities: Skylines Expansion and Content Creator Packs, Launching May 23

The countdown to Cities: Skylines’ sequel continues and last stops on the ‘Cities: Skylines World Tour’ are revealedSTOCKHOLM – April 27, 2023 – Paradox Interactive revealed Cities: Skylines - Hotels & Retreats, the final expansion developed by Colossal Order for their iconic city-building game. Paradox also revealed Industrial Evolution, Railroads of Japan, and Brooklyn & Queens content creator packs, marking the final stops on the ‘Cities: Skylines World Tour’ and offering players increased customization and depth. The Hotels & Retreats expansion and Content Creator Packs will be

Bunker Holding Group secures record-breaking credit facility

Bunker Holding Group, the world’s leading maritime service provider, enters new bank credit facilities of USD 1.11bn and increases its funding framework by 33 percent from USD 2.4bn to USD 3.2bn. The new bank syndicate reflects Bunker Holding Group’s global reach with the addition of large international banks.Bunker Holding Group, the world’s largest bunkering company, lands an unsecured committed bank credit facility of USD 1.11bn based on an international bank syndicate. In addition, the Group’s overall funding framework has been raised to USD 3.2bn, an increase by 33 percent compared to

Fortum Battery Recycling opens Europe’s largest closed-loop hydrometallurgical battery recycling facility in Finland

Fortum Battery Recycling has started commercial operations at its state-of-the-art hydrometallurgical battery material recycling facility in Harjavalta, Finland. The newly established facility is the largest recycling plant in Europe in terms of recycling capacity, and it is also the first commercial-scale facility in Europe for hydrometallurgical recycling. The new large-scale facility will greatly ease the European battery manufacturers’ rising demand for sustainable battery materials, helping to reduce Europe’s dependence on imported critical battery raw materials. “With our new low

Agria UK launches new affiliate programme

Agria Lifetime Equine, a game-changing insurance policy offering horses cover for life, without adding new exclusions from vet cover after claiming, is now welcoming affiliate partners.Swedish-owned pet insurer, Agria, has been providing for the welfare of horses and pets across Europe, since it was the first to insure an animal, a horse, in 1890. Agria Lifetime Equine exploded on to the UK insurance scene last year, becoming a sponsor at Burghley, and supporter of Gareth Hughes, Ros Canter, Joe Stockdale and Natasha Baker.  This year Agria also becomes a major sponsor at Hickstead.

NeoDynamics, Inc. Announces U.S. Availability of NEONAVIA, the First and Only Pulse Biopsy Technology, FDA-Cleared in Breast and Axillary Lymph Node Biopsies.

- NEONAVIA is a new, minimally invasive option designed to provide controlled needle insertion, accurate lesion targeting, and high tissue yield from technically difficult lesions as well as difficult to access pathology. - Commercial launch and introduction of NEONAVIA scheduled at 2 upcoming Conferences for Breast Surgeons and Breast Imaging Professionals. - NEONAVIA PULSE Study abstract has been accepted for electronic presentation at the 2023 SBI Breast Imaging Symposium.MATAWAN, N.J., April 27, 2023 -- NeoDynamics, Inc., a MedTech company pioneering innovative technologies to

There are no items matching the current filter
There are no more items matching the current filter
Back to top